Immunosuppression is an effective treatment strategy for managing acquired long QT syndrome in patients with childhood-onset systemic lupus erythematosus.
Immunosuppression may play a role in treating acquired long QT syndrome secondary to childhood-onset systemic lupus erythematosus.
Absolute Event Rate: 0% vs 0%
This case notes the importance of expedient monitoring and treatment of severely prolonged QTc with concurrent investigation into the etiology. The case also illustrates the role of immunosuppression in the treatment of acquired long QT syndrome in cSLE.
Blasini et al. (Sun,) reported a other. Immunosuppression is an effective treatment strategy for managing acquired long QT syndrome in patients with childhood-onset systemic lupus erythematosus.